Healthcare Sector Stocks
The Healthcare sector has a total of 1059 stocks, with a combined market cap of $9.59 trillion, total revenue of $4.66 trillion and a weighted average PE ratio of 51.43.
Market Cap
9.59T
Revenue
4.66T
Profits
186.48B
PE Ratio
51.43
Profit Margin
4.00%
Dividend Yield
0.37%
1058 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.06T | -3.78% | 1,315,399 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 652.24B | -0.91% | 2,104,621 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 460.76B | -1.90% | 1,033,655 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 378.40B | -1.97% | 3,080,401 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 360.77B | 1.35% | 1,274,882 | 450.53B |
| 6 | NVS | Novartis AG | 303.81B | -1.23% | 567,819 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 263.84B | -2.33% | 1,049,662 | 61.37B |
| 8 | AMGN | Amgen Inc. | 237.35B | -0.73% | 699,759 | 38.10B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 233.77B | 0.65% | 564,939 | 46.34B |
| 10 | NVO | Novo Nordisk A/S | 212.51B | -3.64% | 4,496,383 | 50.34B |
| 11 | ABT | Abbott Laboratories | 198.92B | -1.01% | 2,739,135 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 184.27B | -0.11% | 1,353,730 | 30.46B |
| 13 | PFE | Pfizer Inc. | 161.41B | -0.88% | 12,688,304 | 63.70B |
| 14 | DHR | Danaher Corporation | 151.44B | -0.25% | 622,840 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 139.41B | -0.51% | 195,341 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 138.03B | -0.52% | 1,590,598 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 130.14B | -0.93% | 450,263 | 11.03B |
| 18 | SYK | Stryker Corporation | 126.92B | 0.09% | 533,271 | 25.84B |
| 19 | CVS | CVS Health Corporation | 120.88B | 1.73% | 1,889,132 | 412.65B |
| 20 | MDT | Medtronic plc | 117.63B | 0.83% | 2,062,637 | 36.36B |
| 21 | SNY | Sanofi | 110.09B | -1.09% | 766,535 | 55.89B |
| 22 | MCK | McKesson Corporation | 104.57B | -0.91% | 351,844 | 410.98B |
| 23 | GSK | GSK plc | 104.10B | -0.86% | 732,595 | 44.05B |
| 24 | HCA | HCA Healthcare, Inc. | 92.49B | -0.36% | 459,533 | 78.01B |
| 25 | ELV | Elevance Health, Inc. | 87.43B | 1.07% | 142,501 | 201.11B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 81.79B | -1.73% | 123,139 | 15.53B |
| 27 | CI | The Cigna Group | 74.81B | 1.36% | 325,361 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 68.91B | -4.63% | 19,446,356 | 21.00B |
| 29 | ARGX | argenx SE | 64.17B | 2.80% | 141,003 | 5.32B |
| 30 | COR | Cencora, Inc. | 62.80B | 0.31% | 170,230 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 58.74B | -0.65% | 644,543 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 58.67B | -7.47% | 12,913,999 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 55.43B | 0.18% | 304,939 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 52.37B | -0.01% | 706,643 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 51.81B | 0.22% | 315,721 | 22.48B |
| 36 | NTRA | Natera, Inc. | 48.52B | -0.02% | 480,160 | 2.71B |
| 37 | HUM | Humana Inc. | 46.76B | -0.07% | 266,441 | 145.68B |
| 38 | MDLN | Medline Inc. | 46.45B | -0.87% | 3,300,456 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.65B | 0.77% | 1,177,150 | - |
| 40 | HLN | Haleon plc | 44.39B | 0.34% | 2,938,388 | 14.80B |
| 41 | IDXX | IDEXX Laboratories, Inc. | 43.50B | 0.39% | 105,179 | 4.55B |
| 42 | A | Agilent Technologies, Inc. | 43.34B | -0.86% | 849,265 | 7.23B |
| 43 | TEVA | Teva Pharmaceutical Industries Limited | 43.29B | -2.49% | 1,377,585 | 17.32B |
| 44 | IQV | IQVIA Holdings Inc. | 42.97B | 0.63% | 341,057 | 16.98B |
| 45 | ONC | BeOne Medicines AG | 42.50B | -0.69% | 40,440 | 6.13B |
| 46 | WAT | Waters Corporation | 40.86B | 0.35% | 107,270 | 4.64B |
| 47 | VEEV | Veeva Systems Inc. | 40.03B | -0.13% | 445,678 | 3.32B |
| 48 | RPRX | Royalty Pharma plc | 35.63B | -0.18% | 416,167 | 2.54B |
| 49 | ALC | Alcon Inc. | 35.35B | -0.79% | 318,199 | 10.86B |
| 50 | ILMN | Illumina, Inc. | 34.02B | 0.14% | 714,743 | 4.49B |
| 51 | RMD | ResMed Inc. | 33.90B | -0.66% | 366,320 | 5.65B |
| 52 | DXCM | DexCom, Inc. | 33.39B | -0.76% | 818,623 | 4.97B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 33.28B | -0.30% | 538,756 | 21.27B |
| 54 | CNC | Centene Corporation | 33.05B | 2.92% | 992,049 | 180.30B |
| 55 | BIIB | Biogen Inc. | 32.44B | -0.56% | 213,501 | 10.03B |
| 56 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.22B | 0.29% | 280,604 | 4.80B |
| 57 | ZTS | Zoetis Inc. | 32.15B | 0.66% | 1,889,919 | 9.53B |
| 58 | BNTX | BioNTech SE | 28.07B | -2.01% | 489,833 | 3.03B |
| 59 | MTD | Mettler-Toledo International Inc. | 28.07B | -0.10% | 30,208 | 4.13B |
| 60 | LH | Labcorp Holdings Inc. | 27.26B | -0.46% | 99,455 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 27.06B | 0.27% | 108,767 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 26.75B | -1.79% | 377,799 | 20.18B |
| 63 | INSM | Insmed Incorporated | 26.62B | -1.60% | 431,191 | 1.14B |
| 64 | ROIV | Roivant Sciences Ltd. | 26.34B | - | 1,626,811 | 7.53M |
| 65 | INCY | Incyte Corporation | 26.04B | -0.95% | 181,139 | 5.82B |
| 66 | WST | West Pharmaceutical Services, Inc. | 24.73B | 0.85% | 90,411 | 3.33B |
| 67 | STE | STERIS plc | 23.03B | -0.10% | 79,859 | 6.04B |
| 68 | GH | Guardant Health, Inc. | 22.41B | 1.26% | 643,739 | 1.18B |
| 69 | THC | Tenet Healthcare Corporation | 22.25B | 1.65% | 119,707 | 21.81B |
| 70 | UTHR | United Therapeutics Corporation | 22.10B | -0.61% | 61,556 | 3.15B |
| 71 | GMAB | Genmab A/S | 20.47B | -2.21% | 799,451 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.35B | 0.78% | 1,739,614 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 19.28B | 0.85% | 347,206 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.21B | 0.40% | 47,373 | 2.78B |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -1.45% | 849,411 | 4.60B |
| 76 | ASND | Ascendis Pharma A/S | 16.51B | -0.61% | 59,540 | 1.20B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 15.64B | 0.30% | 267,819 | 3.37B |
| 78 | BBIO | BridgeBio Pharma, Inc. | 15.64B | -0.52% | 397,716 | 713.07M |
| 79 | SOLV | Solventum Corporation | 15.59B | -0.03% | 254,222 | 8.31B |
| 80 | COO | The Cooper Companies, Inc. | 14.15B | -0.64% | 377,707 | 4.23B |
| 81 | CRL | Charles River Laboratories International, Inc. | 14.15B | -0.45% | 165,075 | 4.00B |
| 82 | EXEL | Exelixis, Inc. | 13.99B | -0.48% | 363,840 | 2.44B |
| 83 | RVTY | Revvity, Inc. | 13.95B | 0.14% | 231,811 | 2.91B |
| 84 | BAX | Baxter International Inc. | 13.70B | 0.78% | 1,389,569 | 11.47B |
| 85 | CORT | Corcept Therapeutics Incorporated | 13.25B | -0.80% | 161,638 | 830.81M |
| 86 | ICLR | ICON Public Limited Company | 13.00B | -0.27% | 125,306 | 8.29B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.77B | -0.19% | 750,657 | 3.41B |
| 88 | PEN | Penumbra, Inc. | 12.70B | -0.62% | 162,005 | 1.50B |
| 89 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.55B | -0.07% | 226,423 | 669.50M |
| 90 | ELAN | Elanco Animal Health Incorporated | 12.49B | -0.34% | 962,387 | 5.02B |
| 91 | FMS | Fresenius Medical Care AG | 12.48B | -0.04% | 344,919 | 22.19B |
| 92 | BTSG | BrightSpring Health Services, Inc. | 12.46B | 4.55% | 678,103 | 14.37B |
| 93 | HALO | Halozyme Therapeutics, Inc. | 12.27B | -1.07% | 218,438 | 1.66B |
| 94 | SNN | Smith & Nephew plc | 12.25B | 0.17% | 551,090 | 6.30B |
| 95 | TEM | Tempus AI, Inc. | 12.24B | -1.32% | 2,432,694 | 1.43B |
| 96 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.13B | 2.52% | 60,954 | 1.28B |
| 97 | EHC | Encompass Health Corporation | 11.96B | 0.91% | 183,008 | 6.21B |
| 98 | DVA | DaVita Inc. | 11.59B | 2.18% | 143,937 | 14.01B |
| 99 | ALGN | Align Technology, Inc. | 11.44B | 0.87% | 237,424 | 4.14B |
| 100 | SMMT | Summit Therapeutics Inc. | 11.37B | 6.66% | 7,128,125 | - |
| 101 | TECH | Bio-Techne Corporation | 11.34B | 0.01% | 692,722 | 1.22B |
| 102 | ABVX | ABIVAX Société Anonyme | 11.17B | -0.70% | 219,316 | 5.67M |
| 103 | GMED | Globus Medical, Inc. | 11.10B | -0.38% | 157,870 | 3.14B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 10.96B | 1.81% | 124,629 | 776.57M |
| 105 | CYTK | Cytokinetics, Incorporated | 10.74B | -0.27% | 265,177 | 67.67M |
| 106 | MOH | Molina Healthcare, Inc. | 10.63B | 2.25% | 80,037 | 42.47B |
| 107 | GKOS | Glaukos Corporation | 10.63B | -0.65% | 211,465 | 612.84M |
| 108 | KRYS | Krystal Biotech, Inc. | 10.62B | 0.76% | 92,265 | 440.48M |
| 109 | UHS | Universal Health Services, Inc. | 10.53B | 1.63% | 145,732 | 18.11B |
| 110 | IONS | Ionis Pharmaceuticals, Inc. | 10.51B | -0.53% | 872,355 | 874.09M |
| 111 | PRAX | Praxis Precision Medicines, Inc. | 10.43B | 1.50% | 233,215 | 7.46M |
| 112 | ENSG | The Ensign Group, Inc. | 10.41B | 0.59% | 58,487 | 5.49B |
| 113 | KYMR | Kymera Therapeutics, Inc. | 10.39B | -1.33% | 179,209 | 105.00M |
| 114 | RDY | Dr. Reddy's Laboratories Limited | 10.37B | -0.97% | 392,942 | 3.50B |
| 115 | BIO | Bio-Rad Laboratories, Inc. | 10.32B | -1.09% | 33,831 | 2.59B |
| 116 | RGEN | Repligen Corporation | 10.18B | -0.70% | 162,417 | 785.10M |
| 117 | APGE | Apogee Therapeutics, Inc. | 10.17B | 0.01% | 660,775 | - |
| 118 | HSIC | Henry Schein, Inc. | 10.09B | 1.00% | 187,480 | 13.60B |
| 119 | PODD | Insulet Corporation | 9.92B | 0.01% | 683,817 | 3.05B |
| 120 | AVTR | Avantor, Inc. | 9.79B | 0.35% | 1,206,184 | 6.56B |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 9.72B | -0.21% | 94,173 | 281.99M |
| 122 | OSCR | Oscar Health, Inc. | 9.62B | 0.84% | 1,307,397 | 15.32B |
| 123 | TWST | Twist Bioscience Corporation | 9.48B | -0.11% | 432,671 | 431.80M |
| 124 | PCVX | Vaxcyte, Inc. | 9.05B | -0.43% | 228,853 | - |
| 125 | CRNX | Crinetics Pharmaceuticals, Inc. | 9.00B | -0.02% | 173,593 | 42.16M |
| 126 | QGEN | Qiagen N.V. | 8.99B | -0.41% | 585,700 | 2.10B |
| 127 | IMVT | Immunovant, Inc. | 8.96B | -0.25% | 128,207 | - |
| 128 | HQY | HealthEquity, Inc. | 8.71B | -1.15% | 207,716 | 1.34B |
| 129 | IBRX | ImmunityBio, Inc. | 8.68B | - | 4,494,858 | 165.79M |
| 130 | BRKR | Bruker Corporation | 8.64B | -0.25% | 564,775 | 3.50B |
| 131 | ATR | AptarGroup, Inc. | 8.60B | 0.42% | 39,968 | 3.93B |
| 132 | SYRE | Spyre Therapeutics, Inc. | 8.22B | -13.19% | 1,323,456 | - |
| 133 | ALKS | Alkermes plc | 8.20B | -0.63% | 163,803 | 1.67B |
| 134 | TXG | 10x Genomics, Inc. | 8.16B | -3.20% | 1,471,678 | 616.91M |
| 135 | TGTX | TG Therapeutics, Inc. | 7.79B | -0.94% | 289,946 | 799.54M |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.74B | -0.88% | 91,743 | 239.92M |
| 137 | CAI | Caris Life Sciences, Inc. | 7.45B | -5.82% | 1,623,817 | 989.61M |
| 138 | SRRK | Scholar Rock Holding Corporation | 7.37B | 3.88% | 1,030,407 | - |
| 139 | HNGE | Hinge Health, Inc. | 7.36B | 1.54% | 453,853 | 720.06M |
| 140 | CHE | Chemed Corporation | 7.14B | 0.90% | 38,868 | 2.60B |
| 141 | GRFS | Grifols, S.A. | 7.04B | -1.24% | 246,673 | 8.48B |
| 142 | HIMS | Hims & Hers Health, Inc. | 7.03B | -5.15% | 4,224,959 | 2.58B |
| 143 | PACS | PACS Group, Inc. | 6.98B | 0.32% | 99,450 | 5.55B |
| 144 | CGON | CG Oncology, Inc. | 6.91B | -1.23% | 79,063 | 6.23M |
| 145 | ERAS | Erasca, Inc. | 6.76B | 8.78% | 3,852,352 | - |
| 146 | ORKA | Oruka Therapeutics, Inc. | 6.69B | -0.71% | 138,381 | - |
| 147 | LNTH | Lantheus Holdings, Inc. | 6.59B | 0.10% | 276,456 | 1.56B |
| 148 | LQDA | Liquidia Corporation | 6.38B | 1.18% | 223,032 | 450.91M |
| 149 | BLTE | Belite Bio, Inc | 6.37B | -2.18% | 44,844 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 6.37B | -0.30% | 303,197 | - |
| 151 | MIRM | Mirum Pharmaceuticals, Inc. | 6.31B | -0.93% | 77,090 | 618.07M |
| 152 | TVTX | Travere Therapeutics, Inc. | 6.24B | -1.21% | 338,551 | 591.33M |
| 153 | AMRX | Amneal Pharmaceuticals, Inc. | 6.22B | -0.33% | 335,421 | 3.12B |
| 154 | STVN | Stevanato Group S.p.A. | 6.20B | -0.04% | 74,063 | 1.40B |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 6.19B | -1.21% | 85,824 | 1.90M |
| 156 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.13B | -2.08% | 145,770 | 840.85M |
| 157 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | 4.65% | 346,886 | 7.50M |
| 158 | BLCO | Bausch + Lomb Corporation | 6.10B | -0.99% | 61,905 | 5.32B |
| 159 | PTCT | PTC Therapeutics, Inc. | 6.09B | -0.63% | 120,787 | 1.01B |
| 160 | DFTX | Definium Therapeutics, Inc. | 5.97B | -0.80% | 611,564 | - |
| 161 | RDNT | RadNet, Inc. | 5.97B | -1.37% | 82,980 | 2.27B |
| 162 | TFX | Teleflex Incorporated | 5.93B | -0.24% | 88,145 | 2.25B |
| 163 | LGND | Ligand Pharmaceuticals Incorporated | 5.71B | 1.67% | 52,660 | 290.54M |
| 164 | CRSP | CRISPR Therapeutics AG | 5.64B | -4.30% | 379,553 | 13.39M |
| 165 | SHC | Sotera Health Company | 5.57B | 0.10% | 445,250 | 1.22B |
| 166 | MMED | MiniMed Group, Inc. | 5.43B | 2.17% | 418,609 | 3.10B |
| 167 | MMSI | Merit Medical Systems, Inc. | 5.34B | -1.91% | 164,787 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 5.08B | -3.53% | 544,247 | 1.14B |
| 169 | HAE | Haemonetics Corporation | 4.88B | -0.91% | 130,522 | 1.35B |
| 170 | DYN | Dyne Therapeutics, Inc. | 4.85B | -1.33% | 342,638 | - |
| 171 | PBLS | Parabilis Medicines, Inc. | 4.76B | -1.73% | 68,012 | 148.00K |
| 172 | EWTX | Edgewise Therapeutics, Inc. | 4.74B | -1.33% | 168,715 | - |
| 173 | LFST | LifeStance Health Group, Inc. | 4.71B | 0.49% | 783,230 | 1.58B |
| 174 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.62B | -1.84% | 725,751 | -665.00K |
| 175 | CELC | Celcuity Inc. | 4.60B | 1.82% | 175,621 | - |
| 176 | WAY | Waystar Holding Corp. | 4.60B | -0.99% | 622,395 | 1.21B |
| 177 | ICUI | ICU Medical, Inc. | 4.54B | -0.44% | 26,066 | 2.16B |
| 178 | BLLN | BillionToOne, Inc. | 4.49B | -4.87% | 250,132 | 397.41M |
| 179 | CON | Concentra Group Holdings Parent, Inc. | 4.49B | 1.21% | 100,843 | 2.29B |
| 180 | DOCS | Doximity, Inc. | 4.47B | 1.35% | 410,561 | 655.57M |
| 181 | ELVN | Enliven Therapeutics, Inc. | 4.47B | -0.10% | 350,404 | - |
| 182 | NVST | Envista Holdings Corporation | 4.46B | 1.09% | 240,879 | 2.86B |
| 183 | MANE | Veradermics, Incorporated | 4.36B | 1.86% | 221,081 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 4.36B | 4.28% | 895,330 | 53.81M |
| 185 | HTFL | HeartFlow, Inc. | 4.31B | -0.54% | 357,093 | 212.07M |
| 186 | LIVN | LivaNova PLC | 4.30B | -1.78% | 205,653 | 1.47B |
| 187 | ITGR | Integer Holdings Corporation | 4.26B | - | 80,223 | 1.84B |
| 188 | RLAY | Relay Therapeutics, Inc. | 4.26B | -5.57% | 1,151,607 | 10.35M |
| 189 | INDV | Indivior Pharmaceuticals, Inc. | 4.25B | 0.03% | 277,788 | 1.33B |
| 190 | ADPT | Adaptive Biotechnologies Corporation | 4.14B | -1.18% | 345,478 | 308.08M |
| 191 | LEGN | Legend Biotech Corporation | 4.02B | -2.68% | 287,640 | 1.27B |
| 192 | IDYA | IDEAYA Biosciences, Inc. | 4.01B | -2.24% | 309,756 | 234.13M |
| 193 | VKTX | Viking Therapeutics, Inc. | 3.99B | 0.06% | 391,007 | - |
| 194 | ABCL | AbCellera Biologics Inc. | 3.93B | -3.00% | 2,398,889 | 66.17M |
| 195 | IRTC | iRhythm Holdings, Inc. | 3.90B | -3.88% | 114,533 | 825.34M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.90B | -3.07% | 238,159 | 117.00M |
| 197 | DNLI | Denali Therapeutics Inc. | 3.89B | -2.29% | 226,994 | 3.60M |
| 198 | TLX | Telix Pharmaceuticals Limited | 3.77B | -5.13% | 77,693 | 890.79M |
| 199 | IOVA | Iovance Biotherapeutics, Inc. | 3.71B | -3.08% | 3,959,097 | 324.97M |
| 200 | OGN | Organon & Co. | 3.61B | -0.04% | 1,063,326 | 6.13B |
| 201 | OPCH | Option Care Health, Inc. | 3.57B | 0.80% | 207,064 | 5.69B |
| 202 | NHC | National HealthCare Corporation | 3.51B | -0.19% | 50,453 | 1.56B |
| 203 | GRAL | GRAIL, Inc. | 3.51B | -4.79% | 116,711 | 165.26M |
| 204 | QURE | uniQure N.V. | 3.50B | -1.06% | 299,227 | 18.67M |
| 205 | PLSE | Pulse Biosciences, Inc. | 3.50B | 0.04% | 88,630 | 1.19M |
| 206 | VCYT | Veracyte, Inc. | 3.49B | -1.34% | 1,065,432 | 561.90M |
| 207 | GPCR | Structure Therapeutics Inc. | 3.48B | -2.22% | 85,651 | - |
| 208 | IMNM | Immunome, Inc. | 3.29B | -1.53% | 164,592 | 4.02M |
| 209 | NAMS | NewAmsterdam Pharma Company N.V. | 3.23B | -1.13% | 225,411 | 7.12M |
| 210 | MBX | MBX Biosciences, Inc. | 3.22B | -2.42% | 58,531 | - |
| 211 | WRBY | Warby Parker Inc. | 3.22B | 0.23% | 233,825 | 911.61M |
| 212 | CLDX | Celldex Therapeutics, Inc. | 3.17B | -2.18% | 156,826 | 158.00K |
| 213 | TMDX | TransMedics Group, Inc. | 3.15B | -2.85% | 134,868 | 668.47M |
| 214 | IRON | Disc Medicine, Inc. | 3.15B | -0.38% | 98,611 | - |
| 215 | ARQT | Arcutis Biotherapeutics, Inc. | 3.15B | 0.72% | 388,518 | 463.98M |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | -1.36% | 82,949 | 606.33M |
| 217 | ALMS | Alumis Inc. | 3.07B | -1.00% | 187,243 | 7.40M |
| 218 | AVAH | Aveanna Healthcare Holdings Inc. | 3.02B | 1.69% | 734,213 | 2.60B |
| 219 | BEAM | Beam Therapeutics Inc. | 2.97B | -4.06% | 474,928 | 156.04M |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.96B | 5.00% | 2,555,709 | 4.58B |
| 221 | ACHC | Acadia Healthcare Company, Inc. | 2.93B | 5.42% | 958,233 | 3.37B |
| 222 | ZLAB | Zai Lab Limited | 2.92B | -0.50% | 590,503 | 449.61M |
| 223 | BKD | Brookdale Senior Living Inc. | 2.89B | -0.82% | 761,175 | 2.93B |
| 224 | ATAI | AtaiBeckley Inc. | 2.75B | -0.40% | 1,856,434 | 4.47M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.75B | -1.82% | 177,823 | 36.77M |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.74B | - | 29,398 | - |
| 227 | SLS | SELLAS Life Sciences Group, Inc. | 2.74B | -3.83% | 2,221,661 | - |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.73B | -0.39% | 185,915 | 71.13M |
| 229 | PRVA | Privia Health Group, Inc. | 2.71B | 0.24% | 138,718 | 2.36B |
| 230 | AXGN | Axogen, Inc. | 2.71B | 1.04% | 150,800 | 251.17M |
| 231 | PGEN | Precigen, Inc. | 2.70B | 3.78% | 3,414,129 | 85.72M |
| 232 | WGS | GeneDx Holdings Corp. | 2.64B | 1.38% | 140,551 | 454.43M |
| 233 | SUPN | Supernus Pharmaceuticals, Inc. | 2.63B | -0.42% | 140,851 | 830.44M |
| 234 | VERA | Vera Therapeutics, Inc. | 2.62B | 3.19% | 953,821 | - |
| 235 | PHVS | Pharvaris N.V. | 2.60B | -0.62% | 94,742 | - |
| 236 | RARE | Ultragenyx Pharmaceutical Inc. | 2.57B | -1.21% | 447,960 | 717.00M |
| 237 | NEOG | Neogen Corporation | 2.57B | 1.12% | 444,583 | 870.40M |
| 238 | CDNA | CareDx, Inc. | 2.55B | -3.01% | 513,819 | 458.09M |
| 239 | TRVI | Trevi Therapeutics, Inc. | 2.53B | -1.11% | 215,197 | - |
| 240 | NKTR | Nektar Therapeutics | 2.52B | -1.36% | 96,680 | 54.59M |
| 241 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.51B | -0.25% | 615,597 | 940.61M |
| 242 | BHC | Bausch Health Companies Inc. | 2.49B | -0.89% | 656,833 | 10.85B |
| 243 | NUVB | Nuvation Bio Inc. | 2.49B | -0.28% | 1,069,045 | 169.90M |
| 244 | RAPP | Rapport Therapeutics, Inc. | 2.47B | 0.59% | 60,409 | 20.00M |
| 245 | PBH | Prestige Consumer Healthcare Inc. | 2.46B | 1.13% | 54,510 | 1.10B |
| 246 | KOD | Kodiak Sciences Inc. | 2.43B | -1.95% | 93,331 | - |
| 247 | ATRC | AtriCure, Inc. | 2.42B | -2.21% | 251,680 | 569.62M |
| 248 | BHVN | Biohaven Ltd. | 2.42B | 11.27% | 5,378,613 | - |
| 249 | GRDN | Guardian Pharmacy Services, Inc. | 2.38B | 0.62% | 101,418 | 1.46B |
| 250 | OCUL | Ocular Therapeutix, Inc. | 2.37B | -0.83% | 446,159 | 52.06M |
| 251 | UFPT | UFP Technologies, Inc. | 2.33B | -0.94% | 46,255 | 631.64M |
| 252 | MRVI | Maravai LifeSciences Holdings, Inc. | 2.31B | -1.11% | 2,389,762 | 208.78M |
| 253 | COAG | Hemab Therapeutics Holdings, Inc. | 2.30B | -0.65% | 108,684 | - |
| 254 | KLRA | Kailera Therapeutics, Inc. | 2.30B | - | 192,717 | - |
| 255 | HRMY | Harmony Biosciences Holdings, Inc. | 2.29B | 0.95% | 323,561 | 959.90M |
| 256 | MLYS | Mineralys Therapeutics, Inc. | 2.27B | -2.39% | 203,038 | - |
| 257 | BFLY | Butterfly Network, Inc. | 2.27B | -5.75% | 1,930,814 | 112.14M |
| 258 | URGN | UroGen Pharma Ltd. | 2.26B | -0.09% | 292,436 | 188.73M |
| 259 | ALMR | Alamar Biosciences, Inc. | 2.26B | -1.24% | 141,482 | 100.42M |
| 260 | TRLV | Trulieve Cannabis Corp. | 2.26B | 3.71% | 709,086 | 1.14B |
| 261 | ADUS | Addus HomeCare Corporation | 2.24B | 1.00% | 37,671 | 1.48B |
| 262 | CLOV | Clover Health Investments, Corp. | 2.22B | 1.09% | 1,449,871 | 2.48B |
| 263 | AUPH | Aurinia Pharmaceuticals Inc. | 2.20B | -1.43% | 262,779 | 311.51M |
| 264 | MESO | Mesoblast Limited | 2.19B | -2.79% | 46,592 | 65.38M |
| 265 | XRAY | DENTSPLY SIRONA Inc. | 2.19B | 0.27% | 738,303 | 3.64B |
| 266 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 2.16% | 51,123 | - |
| 267 | GENB | Generate Biomedicines, Inc. | 2.18B | -16.73% | 1,959,434 | 26.48M |
| 268 | ESTA | Establishment Labs Holdings Inc. | 2.18B | 1.17% | 62,274 | 245.82M |
| 269 | VCEL | Vericel Corporation | 2.18B | -1.71% | 77,289 | 306.30M |
| 270 | NEO | NeoGenomics, Inc. | 2.17B | 0.45% | 359,222 | 766.30M |
| 271 | ZBIO | Zenas BioPharma, Inc. | 2.14B | -2.67% | 168,708 | 1.00M |
| 272 | STOK | Stoke Therapeutics, Inc. | 2.14B | -0.87% | 175,497 | 27.59M |
| 273 | ADMA | ADMA Biologics, Inc. | 2.14B | -1.70% | 381,272 | 512.28M |
| 274 | XNCR | Xencor, Inc. | 2.13B | -2.22% | 648,781 | 104.97M |
| 275 | MD | Pediatrix Medical Group, Inc. | 2.13B | -0.67% | 170,801 | 1.95B |
| 276 | HCM | HUTCHMED (China) Limited | 2.12B | 1.14% | 29,970 | 549.12M |
| 277 | NBTX | Nanobiotix S.A. | 2.12B | -3.32% | 54,898 | 38.27M |
| 278 | ZYME | Zymeworks Inc. | 2.07B | 6.12% | 700,228 | 37.13M |
| 279 | NVCR | NovoCure Limited | 2.05B | -0.17% | 179,290 | 699.19M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | 0.44% | 173,995 | 98.34M |
| 281 | PRGO | Perrigo Company plc | 2.03B | 0.97% | 705,831 | 4.14B |
| 282 | CMPS | COMPASS Pathways plc | 2.03B | -1.61% | 760,973 | - |
| 283 | PGNY | Progyny, Inc. | 1.99B | 0.66% | 234,020 | 1.31B |
| 284 | ASTH | Astrana Health, Inc. | 1.99B | 3.26% | 78,350 | 3.84B |
| 285 | GHRS | GH Research PLC | 1.97B | -0.93% | 21,493 | - |
| 286 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | -1.96% | 340,793 | 1.97B |
| 287 | KARD | Kardigan, Inc. | 1.94B | -0.86% | 75,849 | - |
| 288 | FBRX | Forte Biosciences, Inc. | 1.94B | 0.03% | 1,044,621 | - |
| 289 | TSHA | Taysha Gene Therapies, Inc. | 1.94B | -4.03% | 357,556 | 5.49M |
| 290 | LKFT | Lakefront Biotherapeutics NV | 1.93B | -0.79% | 71,891 | 1.13B |
| 291 | SNDA | Sonida Senior Living, Inc. | 1.91B | -1.71% | 109,645 | 481.07M |
| 292 | DMRA | Damora Therapeutics, Inc. | 1.90B | 0.33% | 45,501 | - |
| 293 | IMCR | Immunocore Holdings plc | 1.90B | -1.60% | 51,149 | 430.78M |
| 294 | SEPN | Septerna, Inc. | 1.89B | -2.05% | 41,770 | 98.88M |
| 295 | SGRY | Surgery Partners, Inc. | 1.86B | 2.21% | 1,387,373 | 3.37B |
| 296 | RXRX | Recursion Pharmaceuticals, Inc. | 1.86B | -2.81% | 6,385,422 | 54.86M |
| 297 | INBX | Inhibrx Biosciences, Inc. | 1.85B | 2.68% | 125,004 | 1.30M |
| 298 | NTLA | Intellia Therapeutics, Inc. | 1.83B | -3.48% | 1,302,796 | 59.51M |
| 299 | LMAT | LeMaitre Vascular, Inc. | 1.82B | 0.84% | 40,624 | 262.43M |
| 300 | BLFS | BioLife Solutions, Inc. | 1.82B | -0.05% | 196,969 | 106.69M |
| 301 | PSNL | Personalis, Inc. | 1.81B | -1.74% | 951,830 | 69.67M |
| 302 | VIR | Vir Biotechnology, Inc. | 1.79B | -1.21% | 699,791 | 303.23M |
| 303 | BRVE | Braveheart Bio, Inc. | 1.79B | 0.76% | 89,576 | - |
| 304 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.05% | 247,355 | 252.25M |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.78B | -1.51% | 148,953 | 105.60M |
| 306 | INSP | Inspire Medical Systems, Inc. | 1.77B | 0.18% | 54,813 | 898.74M |
| 307 | ALVO | Alvotech | 1.77B | -1.98% | 510,424 | 494.61M |
| 308 | FTRE | Fortrea Holdings Inc. | 1.73B | -0.55% | 163,538 | 2.68B |
| 309 | ANAB | AnaptysBio, Inc. | 1.71B | -1.12% | 48,241 | 232.39M |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.66B | -1.91% | 81,457 | 20.00M |
| 311 | AVLN | Avalyn Pharma Inc. | 1.64B | -3.06% | 33,346 | - |
| 312 | BCAX | Bicara Therapeutics Inc. | 1.62B | -0.49% | 76,956 | - |
| 313 | AGL | agilon health, inc. | 1.62B | 0.18% | 39,031 | 5.92B |
| 314 | XERS | Xeris Biopharma Holdings, Inc. | 1.60B | 0.69% | 345,718 | 335.41M |
| 315 | ANIP | ANI Pharmaceuticals, Inc. | 1.60B | -1.32% | 124,528 | 978.38M |
| 316 | ARDT | Ardent Health, Inc. | 1.60B | 0.09% | 99,091 | 6.41B |
| 317 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | -1.86% | 157,099 | - |
| 318 | APMD | Apnimed, Inc. | 1.58B | 4.13% | 106,849 | 120.15M |
| 319 | TYRA | Tyra Biosciences, Inc. | 1.57B | -1.22% | 54,462 | - |
| 320 | HCSG | Healthcare Services Group, Inc. | 1.57B | -0.44% | 117,358 | 1.86B |
| 321 | LBRX | LB Pharmaceuticals Inc | 1.56B | -0.82% | 105,806 | - |
| 322 | KMTS | Kestra Medical Technologies, Ltd. | 1.55B | -1.56% | 64,232 | 95.13M |
| 323 | AAPG | Ascentage Pharma Group International | 1.55B | 1.31% | 3,206 | 94.61M |
| 324 | INVA | Innoviva, Inc. | 1.53B | 0.24% | 139,426 | 440.00M |
| 325 | ABSI | Absci Corporation | 1.53B | -7.48% | 1,422,644 | 1.56M |
| 326 | AVBP | ArriVent BioPharma, Inc. | 1.52B | -1.37% | 129,997 | - |
| 327 | NVAX | Novavax, Inc. | 1.52B | -2.28% | 1,895,933 | 413.80M |
| 328 | LTGO | Latigo Biotherapeutics, Inc. | 1.52B | 6.42% | 53,921 | - |
| 329 | OMCL | Omnicell, Inc. | 1.52B | 0.24% | 152,880 | 1.25B |
| 330 | INNV | InnovAge Holding Corp. | 1.52B | 2.47% | 49,092 | 949.17M |
| 331 | SLBT | SL Science Holding Limited | 1.51B | 0.34% | 5,443 | 3.27M |
| 332 | CNMD | CONMED Corporation | 1.51B | -1.64% | 48,666 | 1.37B |
| 333 | FRNM | Freenome, Inc. | 1.50B | 0.07% | 203,281 | 35.41M |
| 334 | TNDM | Tandem Diabetes Care, Inc. | 1.48B | -1.48% | 224,606 | 1.04B |
| 335 | HROW | Harrow, Inc. | 1.48B | -4.67% | 146,419 | 275.59M |
| 336 | CGEM | Cullinan Therapeutics, Inc. | 1.48B | -0.07% | 173,076 | - |
| 337 | OMDA | Omada Health, Inc. | 1.47B | 0.61% | 87,602 | 309.76M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.47B | 0.64% | 61,844 | 1.50B |
| 339 | AKTS | Aktis Oncology, Inc. | 1.46B | -1.35% | 121,886 | 10.06M |
| 340 | REPL | Replimune Group, Inc. | 1.46B | -1.65% | 533,006 | - |
| 341 | ENOV | Enovis Corporation | 1.46B | -1.17% | 97,958 | 2.30B |
| 342 | SDGR | Schrödinger, Inc. | 1.45B | -3.28% | 276,136 | 259.04M |
| 343 | ATEC | Alphatec Holdings, Inc. | 1.44B | -0.05% | 331,567 | 815.05M |
| 344 | AZTA | Azenta, Inc. | 1.44B | -1.11% | 138,397 | 613.81M |
| 345 | SVRA | Savara Inc. | 1.42B | -0.09% | 593,429 | - |
| 346 | ORIC | ORIC Pharmaceuticals, Inc. | 1.41B | -1.37% | 290,188 | - |
| 347 | ANRO | Alto Neuroscience, Inc. | 1.41B | -1.14% | 86,093 | - |
| 348 | VOR | Vor Biopharma Inc. | 1.40B | -1.79% | 141,854 | - |
| 349 | MGTX | MeiraGTx Holdings plc | 1.38B | -3.35% | 169,139 | 397.50M |
| 350 | JBIO | Jade Biosciences, Inc. | 1.37B | -1.33% | 66,000 | - |
| 351 | SPTX | Seaport Therapeutics, Inc. | 1.37B | 3.02% | 21,533 | - |
| 352 | DRTS | Alpha Tau Medical Ltd. | 1.37B | 0.68% | 85,150 | - |
| 353 | PNTG | The Pennant Group, Inc. | 1.35B | 1.07% | 35,013 | 1.10B |
| 354 | NUTX | Nutex Health Inc. | 1.33B | 3.14% | 64,124 | 846.72M |
| 355 | OMER | Omeros Corporation | 1.33B | -4.82% | 542,577 | 38.42M |
| 356 | MNKD | MannKind Corporation | 1.32B | -1.68% | 535,978 | 393.63M |
| 357 | MLTX | MoonLake Immunotherapeutics | 1.31B | -0.77% | 285,767 | - |
| 358 | AMN | AMN Healthcare Services, Inc. | 1.30B | -0.80% | 276,100 | 3.43B |
| 359 | IART | Integra LifeSciences Holdings Corporation | 1.30B | -0.24% | 61,020 | 1.65B |
| 360 | AORT | Artivion, Inc. | 1.30B | 1.02% | 89,223 | 471.47M |
| 361 | CRON | Cronos Group Inc. | 1.29B | -0.14% | 627,681 | 179.09M |
| 362 | IMTX | Immatics N.V. | 1.25B | -1.08% | 278,946 | 47.65M |
| 363 | CERT | Certara, Inc. | 1.24B | - | 250,907 | 421.75M |
| 364 | CRVS | Corvus Pharmaceuticals, Inc. | 1.24B | 1.24% | 213,201 | - |
| 365 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | -2.20% | 370,088 | 28.73M |
| 366 | SANA | Sana Biotechnology, Inc. | 1.21B | -1.10% | 814,159 | - |
| 367 | PRCT | PROCEPT BioRobotics Corporation | 1.21B | -2.04% | 268,637 | 337.34M |
| 368 | GDRX | GoodRx Holdings, Inc. | 1.20B | 1.29% | 347,686 | 785.23M |
| 369 | ODTX | Odyssey Therapeutics, Inc. | 1.20B | -4.69% | 83,624 | 99.00K |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.17B | 1.56% | 69,195 | 804.27M |
| 371 | KURA | Kura Oncology, Inc. | 1.17B | -3.24% | 899,442 | 77.23M |
| 372 | BVS | Bioventus Inc. | 1.16B | -2.06% | 113,602 | 581.85M |
| 373 | TDOC | Teladoc Health, Inc. | 1.15B | 2.10% | 1,071,225 | 2.49B |
| 374 | STAA | STAAR Surgical Company | 1.14B | -1.60% | 178,893 | 339.59M |
| 375 | JANX | Janux Therapeutics, Inc. | 1.14B | -0.21% | 158,511 | 24.00M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 1.14B | -1.82% | 55,873 | 1.04B |
| 377 | IVA | Inventiva S.A. | 1.13B | 1.81% | 286,427 | 7.94M |
| 378 | IRMD | IRADIMED CORPORATION | 1.12B | -0.51% | 35,390 | 86.34M |
| 379 | OPK | OPKO Health, Inc. | 1.11B | - | 1,657,404 | 587.90M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.08B | 2.13% | 216,083 | 59.00K |
| 381 | SLDB | Solid Biosciences Inc. | 1.04B | -2.22% | 173,226 | - |
| 382 | PCRX | Pacira BioSciences, Inc. | 1.04B | 1.84% | 130,253 | 746.16M |
| 383 | CSTL | Castle Biosciences, Inc. | 1.04B | -3.09% | 115,488 | 357.28M |
| 384 | WVE | Wave Life Sciences, Inc. | 1.03B | -0.19% | 401,175 | 65.37M |
| 385 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.10% | 781,088 | 181.72M |
| 386 | CADL | Candel Therapeutics, Inc. | 1.02B | -1.84% | 587,112 | - |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.02B | -1.92% | 510,278 | 41.47M |
| 388 | QDEL | QuidelOrtho Corporation | 1.02B | -1.53% | 130,203 | 2.67B |
| 389 | GMRS | GMR Solutions Inc. | 1.00B | 1.57% | 65,739 | 5.88B |
| 390 | IMMX | Immix Biopharma, Inc. | 1.00B | -3.18% | 612,437 | - |
| 391 | HELP | Cybin Inc. | 1.00B | -2.11% | 853,249 | - |
| 392 | DSGN | Design Therapeutics, Inc. | 981.91M | 0.06% | 244,576 | - |
| 393 | GERN | Geron Corporation | 979.77M | -1.61% | 2,174,110 | 204.56M |
| 394 | GLAS | Glass House Brands Inc. | 977.77M | 2.42% | 125,692 | 176.98M |
| 395 | ARDX | Ardelyx, Inc. | 956.88M | 1.59% | 860,644 | 450.89M |
| 396 | CLYM | Climb Bio, Inc. | 955.74M | -6.73% | 495,479 | - |
| 397 | ANNX | Annexon, Inc. | 955.48M | -2.14% | 493,829 | - |
| 398 | AMPH | Amphastar Pharmaceuticals, Inc. | 946.47M | 1.23% | 79,526 | 730.02M |
| 399 | OLMA | Olema Pharmaceuticals, Inc. | 944.97M | -1.01% | 119,131 | - |
| 400 | ACRS | Aclaris Therapeutics, Inc. | 914.11M | -4.97% | 687,613 | 8.22M |
| 401 | COLL | Collegium Pharmaceutical, Inc. | 913.51M | 2.15% | 163,507 | 808.21M |
| 402 | ANL | Adlai Nortye Ltd. | 908.01M | 2.62% | 32,048 | 18.06M |
| 403 | CBLL | CeriBell, Inc. | 899.58M | -2.13% | 81,269 | 101.96M |
| 404 | FTH | Faeth Therapeutics, Inc. | 888.65M | -0.38% | 56,531 | - |
| 405 | SIBN | SI-BONE, Inc. | 885.62M | 1.13% | 122,801 | 213.60M |
| 406 | TBPH | Theravance Biopharma, Inc. | 884.70M | 0.06% | 79,537 | 104.31M |
| 407 | SGP | SpyGlass Pharma, Inc. | 880.02M | -1.09% | 11,667 | - |
| 408 | DBVT | DBV Technologies S.A. | 873.69M | -4.24% | 92,891 | 5.04M |
| 409 | AVR | Anteris Technologies Global Corp. | 865.92M | -0.06% | 145,817 | 2.24M |
| 410 | BBNX | Beta Bionics, Inc. | 863.35M | -0.78% | 70,490 | 119.01M |
| 411 | INMD | InMode Ltd. | 860.49M | -0.40% | 83,426 | 374.63M |
| 412 | RIGL | Rigel Pharmaceuticals, Inc. | 852.85M | -2.34% | 62,780 | 276.79M |
| 413 | FDMT | 4D Molecular Therapeutics, Inc. | 844.13M | -2.80% | 233,254 | 92.01M |
| 414 | HSTM | HealthStream, Inc. | 840.21M | -0.47% | 32,548 | 321.12M |
| 415 | AHG | Akso Health Group | 839.31M | -0.46% | 815 | 13.83M |
| 416 | ACHV | Achieve Life Sciences, Inc. | 837.11M | -0.43% | 214,143 | - |
| 417 | PHAR | Pharming Group N.V. | 830.52M | 2.21% | 16,746 | 366.48M |
| 418 | ATTO | Attovia Therapeutics, Inc. | 829.17M | -0.21% | 38,873 | 1.35M |
| 419 | SLN | Silence Therapeutics plc | 814.33M | -1.06% | 63,573 | 615.00K |
| 420 | STTK | Shattuck Labs, Inc. | 800.90M | -0.99% | 183,108 | 1.00M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 800.20M | -5.14% | 132,651 | - |
| 422 | AURA | Aura Biosciences, Inc. | 799.56M | -1.41% | 101,793 | - |
| 423 | OCS | Oculis Holding AG | 796.34M | -0.46% | 46,744 | 1.45M |
| 424 | OBX | Obsidian Therapeutics, Inc. | 787.67M | -4.32% | 84,823 | - |
| 425 | NGNE | Neurogene Inc. | 782.45M | -4.26% | 50,114 | 925.00K |
| 426 | DRUG | Bright Minds Biosciences Inc. | 782.27M | -2.52% | 29,885 | - |
| 427 | VREX | Varex Imaging Corporation | 780.16M | 0.05% | 98,236 | 865.00M |
| 428 | CBIO | Crescent Biopharma, Inc. | 775.56M | 6.59% | 123,551 | 11.88M |
| 429 | MNPR | Monopar Therapeutics Inc. | 746.33M | 0.33% | 64,245 | - |
| 430 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 743.22M | -1.07% | 41,130 | - |
| 431 | SSII | SS Innovations International, Inc. | 739.42M | 3.94% | 8,379 | 52.40M |
| 432 | AHCO | AdaptHealth Corp. | 737.75M | 0.91% | 485,869 | 3.36B |
| 433 | ASMB | Assembly Biosciences, Inc. | 723.72M | 0.61% | 59,487 | 74.85M |
| 434 | SOPH | SOPHiA GENETICS SA | 723.59M | -1.73% | 83,033 | 86.17M |
| 435 | CTMX | CytomX Therapeutics, Inc. | 721.25M | -1.78% | 724,555 | 18.30M |
| 436 | PHR | Phreesia, Inc. | 715.78M | 0.52% | 136,652 | 495.59M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 712.97M | -3.29% | 42,797 | - |
| 438 | GYRE | Gyre Therapeutics, Inc. | 708.31M | - | 13,934 | 109.82M |
| 439 | IRWD | Ironwood Pharmaceuticals, Inc. | 707.23M | -2.51% | 339,951 | 389.32M |
| 440 | AGMB | AgomAb Therapeutics NV | 704.98M | 2.10% | 121,771 | - |
| 441 | ALLO | Allogene Therapeutics, Inc. | 703.07M | -6.22% | 1,897,676 | 4.64M |
| 442 | ZVRA | Zevra Therapeutics, Inc. | 700.13M | -2.08% | 187,620 | 136.07M |
| 443 | PHAT | Phathom Pharmaceuticals, Inc. | 697.40M | -0.23% | 268,970 | 239.66M |
| 444 | OABI | OmniAb, Inc. | 686.24M | 1.29% | 410,051 | 38.46M |
| 445 | EVO | Evotec SE | 674.99M | 2.12% | 14,411 | 819.47M |
| 446 | PRLD | Prelude Therapeutics Incorporated | 664.32M | -2.12% | 218,922 | 22.42M |
| 447 | AQST | Aquestive Therapeutics, Inc. | 662.07M | 3.84% | 1,108,191 | 54.09M |
| 448 | EIKN | Eikon Therapeutics, Inc. | 660.27M | -2.87% | 139,765 | - |
| 449 | MPLT | MapLight Therapeutics, Inc. | 659.13M | -5.42% | 80,507 | - |
| 450 | STLN | Starling Oncology, Inc. | 658.38M | 2.54% | 344,336 | 587.24M |
| 451 | CRMD | CorMedix Inc. | 654.73M | -1.87% | 252,870 | 462.25M |
| 452 | SGMT | Sagimet Biosciences Inc. | 648.63M | 1.41% | 282,365 | - |
| 453 | ANGO | AngioDynamics, Inc. | 646.03M | -2.01% | 84,499 | 320.17M |
| 454 | VALN | Valneva SE | 640.49M | -1.77% | 10,684 | 163.30M |
| 455 | MDXG | MiMedx Group, Inc. | 637.70M | 0.81% | 223,489 | 355.17M |
| 456 | KIDS | OrthoPediatrics Corp. | 634.34M | -0.84% | 44,503 | 252.72M |
| 457 | TLRY | Tilray Brands, Inc. | 631.96M | -4.51% | 1,749,755 | 915.45M |
| 458 | VSTM | Verastem, Inc. | 631.23M | -1.55% | 174,567 | 87.53M |
| 459 | CTNM | Contineum Therapeutics, Inc. | 629.40M | -1.88% | 137,820 | - |
| 460 | CTEV | Claritev Corporation | 627.23M | -1.67% | 18,605 | 994.67M |
| 461 | AUTL | Autolus Therapeutics plc | 621.49M | -4.30% | 493,787 | 117.39M |
| 462 | PRME | Prime Medicine, Inc. | 614.66M | -6.87% | 882,948 | 4.07M |
| 463 | ARVN | Arvinas, Inc. | 608.09M | -3.12% | 266,122 | 316.70M |
| 464 | ALT | Altimmune, Inc. | 604.95M | -2.81% | 1,278,861 | 31.00K |
| 465 | RGNX | REGENXBIO Inc. | 597.42M | 1.57% | 328,716 | 174.48M |
| 466 | SCTX | Scribe Therapeutics Inc. | 593.85M | 0.88% | 125,106 | 36.28M |
| 467 | EOLS | Evolus, Inc. | 593.13M | 0.06% | 518,650 | 316.49M |
| 468 | ZURA | Zura Bio Limited | 590.31M | -2.53% | 726,357 | - |
| 469 | CTKB | Cytek Biosciences, Inc. | 587.52M | -1.31% | 117,902 | 206.71M |
| 470 | WEAV | Weave Communications, Inc. | 583.99M | 0.14% | 1,969,126 | 257.79M |
| 471 | BWAY | BrainsWay Ltd. | 583.55M | -1.46% | 31,761 | 60.70M |
| 472 | SPRY | ARS Pharmaceuticals, Inc. | 576.79M | 1.40% | 291,118 | 116.93M |
| 473 | DCTH | Delcath Systems, Inc. | 576.52M | -1.80% | 100,404 | 95.42M |
| 474 | ARTV | Artiva Biotherapeutics, Inc. | 576.41M | 0.17% | 67,483 | 251.00K |
| 475 | BLSM | BlossomHill Therapeutics, Inc. | 566.60M | 0.38% | 23,010 | - |
| 476 | OVID | Ovid Therapeutics Inc. | 560.50M | -1.37% | 367,322 | 1.58M |
| 477 | EVH | Evolent Health, Inc. | 556.82M | 0.72% | 486,462 | 2.10B |
| 478 | ENTX | Entera Bio Ltd. | 554.05M | -7.78% | 305,855 | 42.00K |
| 479 | CABA | Cabaletta Bio, Inc. | 545.09M | -0.16% | 729,527 | - |
| 480 | FLGT | Fulgent Genetics, Inc. | 545.08M | -0.70% | 57,752 | 323.93M |
| 481 | CERS | Cerus Corporation | 544.12M | -0.74% | 300,478 | 221.55M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 536.18M | -1.92% | 174,195 | - |
| 483 | SRTA | Strata Critical Medical, Inc. | 536.11M | -2.10% | 143,193 | 255.98M |
| 484 | CAPR | Capricor Therapeutics, Inc. | 534.88M | 10.98% | 7,499,486 | 11.13M |
| 485 | TCMD | Tactile Systems Technology, Inc. | 530.29M | -0.72% | 48,939 | 350.31M |
| 486 | PROK | ProKidney Corp. | 521.51M | -0.29% | 211,544 | 818.00K |
| 487 | RZLT | Rezolute, Inc. | 520.24M | -0.60% | 316,962 | - |
| 488 | EVMN | Evommune, Inc. | 505.19M | 0.94% | 175,783 | 10.00M |
| 489 | CCCC | C4 Therapeutics, Inc. | 504.40M | -2.38% | 749,533 | 35.04M |
| 490 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 491 | NPCE | NeuroPace, Inc. | 496.16M | 2.08% | 45,428 | 106.99M |
| 492 | CLPT | ClearPoint Neuro, Inc. | 495.39M | -4.25% | 194,490 | 42.28M |
| 493 | DNA | Ginkgo Bioworks Holdings, Inc. | 490.91M | -3.32% | 204,623 | 132.42M |
| 494 | KMDA | Kamada Ltd. | 489.99M | -2.03% | 131,060 | 191.85M |
| 495 | EDIT | Editas Medicine, Inc. | 489.15M | -2.90% | 1,511,457 | 47.01M |
| 496 | SENS | Senseonics Holdings, Inc. | 487.50M | -3.15% | 166,390 | 48.55M |
| 497 | EPRX | Eupraxia Pharmaceuticals Inc. | 485.68M | - | 57,719 | - |
| 498 | QTTB | Q32 Bio Inc. | 484.05M | -0.37% | 119,218 | 53.74M |
| 499 | RLMD | Relmada Therapeutics, Inc. | 482.15M | -1.53% | 128,314 | - |
| 500 | NRC | NRC Health | 475.46M | -2.38% | 40,335 | 140.00M |